Tocilizumab is more effective than adalimumab at reducing signs and symptoms of RA
Safety results were similar between groups. Data presented at EULAR 2012, the Annual Congress of the European League Against Rheumatism, demonstrates that tocilizumab monotherapy is more effective than… read more.